miR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 12, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-21
DOI
10.1038/s41419-018-1182-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL
- (2016) A. Shukla et al. BLOOD
- Pancreatic cancer
- (2016) Terumi Kamisawa et al. LANCET
- MicroRNA-1207-5p inhibits hepatocellular carcinoma cell growth and invasion through the fatty acid synthase-mediated Akt/mTOR signalling pathway
- (2016) Gang Zhao et al. ONCOLOGY REPORTS
- MicroRNA-mRNA interactions in colorectal cancer and their role in tumor progression
- (2015) Raheleh Amirkhah et al. GENES CHROMOSOMES & CANCER
- MicroRNAome genome: A treasure for cancer diagnosis and therapy
- (2014) Ioana Berindan-Neagoe et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Interdependent epidermal growth factor receptor signalling and trafficking
- (2014) Sylwia Jones et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR
- (2014) Anne-Theres Henze et al. Nature Communications
- MicroRNAs Cooperatively Inhibit a Network of Tumor Suppressor Genes to Promote Pancreatic Tumor Growth and Progression
- (2013) Adam E. Frampton et al. GASTROENTEROLOGY
- EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal Adenocarcinoma
- (2012) Carolina Navas et al. CANCER CELL
- Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways
- (2012) Chunmei Wang et al. JOURNAL OF HEPATOLOGY
- Clinical Outcome Prediction by MicroRNAs in Human Cancer: A Systematic Review
- (2012) Viswam S. Nair et al. JNCI-Journal of the National Cancer Institute
- Sprouty genes function in suppression of prostate tumorigenesis
- (2012) J. L. Schutzman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miRNA-96 Suppresses KRAS and Functions as a Tumor Suppressor Gene in Pancreatic Cancer
- (2010) S. Yu et al. CANCER RESEARCH
- MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
- (2010) Elisa Giovannetti et al. CANCER RESEARCH
- MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions
- (2010) M. C. du Rieu et al. CLINICAL CHEMISTRY
- EGF Decreases the Abundance of MicroRNAs That Restrain Oncogenic Transcription Factors
- (2010) R. Avraham et al. Science Signaling
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Up-regulation of miR-21 by HER2/neuSignaling Promotes Cell Invasion
- (2009) Tzu-Hsuan Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers
- (2009) M. Seike et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sprouty proteins, masterminds of receptor tyrosine kinase signaling
- (2008) Miguel A. Cabrita et al. ANGIOGENESIS
- An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation
- (2008) F Talotta et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started